UK-VARSS 2025 Highlights
Published 17 November 2026
1. Antibiotic use and resistance
Key trends in antibiotic use and resistance since 2015.
The UK-VARSS report brings together data on antibiotics sales, use and resistance. This allows us to show long term trends and acts as an early warning sign for emerging issues in antibiotic use and resistance.
Infographic to show sales of antibiotics in food-producing animals in mg/kg from 2014-2025:
- 2014 - 36.0
- 2015 - 32.5
- 2016 - 22.9
- 2017 - 19.3
- 2018 - 17.9
- 2019 - 18.7
- 2020 - 18.7
- 2021 - 17.4
- 2022 - 15.7
- 2023 - 15.9
- 2024 - 15.6
- 2025 - 15.9
There was an overall reduction of 57% of antibiotic sales between 2014-2025.
Infographic to show sales of HP-CIAs in mg/kg, in food-producing animals 2014-2025:
- 2014 - 0.38
- 2015 - 0.36
- 2016 - 0.22
- 2017 - 0.15
- 2018 - 0.12
- 2019 - 0.09
- 2020 - 0.08
- 2021 - 0.06
- 2022 - 0.06
- 2023 - 0.06
- 2024 - 0.06
- 2025 - 0.07
There was an overall reduction of 82% of antibiotic sales between 2014-2025.
Infographic to show percentage of fully susceptible E. coli isolates 2014-202 – Full susceptibility means there was no resistance to the antibiotics tested:
- 2014 - 2015: 17.2
- 2015 - 2016: 19.3
- 2016 - 2017: 22.1
- 2017 - 2018: 34.0
- 2018 - 2019: 33.2
- 2019 - 2020: 37.7
- 2020 - 2021: 39.3
- 2021 - 2022: 41.1
- 2022 - 2023: 43.5
- 2023 - 2024: 35.1
- 2024 - 2025: 34.1
There was an overall increase of 16.9% in percentage of fully susceptible E. coli isolates between 2014-2015.
Infographic to show percentage of multi-drug resistant E.coli isolates 2014-2024. Multi-drug resistance means resistance to three or more classes of antibiotics:
- 2014 - 2015: 57.7
- 2015 - 2016: 49.2
- 2016 - 2017: 45.9
- 2017 - 2018: 35.9
- 2018 - 2019: 35.7
- 2019 - 2020: 30.9
- 2020 - 2021: 30.2
- 2021 - 2022: 30.3
- 2022 - 2023: 26.9
- 2023 - 2024: 26.6
- 2024 - 2025: 29.0
There was an overall decrease of 58% in percentage of multi-drug resistant E. coli isolates between 2014-2024.
2. Antibiotic sales
2.1 Sales for food-producing animals (mg/kg)
Sales of veterinary antibiotics for use in food-producing animals, adjusted for animal population, were 15.9 mg/kg in 2025. This represents a 2% (0.3 mg/kg) increase since 2024 and a 56% (20.2mg/kg) decrease since 2014.
Infographic showing sales in mg/kg between 2014-2025:
- 2014 - 57.7
- 2015 - 49.2
- 2016 - 45.9
- 2017 - 35.9
- 2018 - 35.7
- 2019 - 30.9
- 2020 - 30.2
- 2021 - 30.3
- 2022 - 26.9
- 2023 - 26.6
- 2024 - 15.6
- 2025 - 15.9
Over half of all antibiotics sold were either tetracyclines (33%) or penicillins (21%). Sales of highest priority critically important antibiotics (HP-CIAs) in food-producing animals remain at very low levels (0.07 mg/kg) and account for 0.4% of sales in 2025.
Infographic showing the classes of HP-CIAs and total sales for 2014, 2024 and 2025:
- Total HP-CIAs: In 2014 0.38 mg/kg were sold, in 2024 0.06 mg/kg were sold and in 2025 0.07 mg/kg were sold which represents an 82% decrease since 2014.
- Fluoroquinolones: In 2014 0.2 mg/kg were sold, in 2024 0.05 mg/kg were sold and in 2025 0.06 mg/kg were sold which represents a 71% decrease since 2014.
- 3rd and 4th generation cephalosporins: In 2014 0.11 mg/kg were sold, in 2024 0.01 mg/kg were sold and in 2025 0.01 mg/kg were sold which represents a 93% decrease since 2014.
- Colistin: In 2014 0.07 mg/kg were sold, in 2024 0.00 mg/kg were sold, in 2025 0.0 m/kg were sold which represents a 100% decrease since 2014.
2.2 Sales of antibiotics for all animals in tonnes
Infographic showing the total sales for all animals in tonnes:
- 2014 - 452
- 2015 - 411
- 2016 - 299
- 2017 - 256
- 2018 - 238
- 2019 - 243
- 2020 - 242
- 2021 - 228
- 2022 - 205
- 2023 - 200
- 2024 - 194
- 2025 - 195
There was an overall reduction of 56% in sales of antibiotics for all animals (tonnes) since 2014.
Total amount of HP-CIAs sold in 2025 was 0.83 tonnes representing an increase of 4% (0.03 tonnes) since 2024 and a decrease of 83% (3.9 tonnes) since 2014. Sales of HP-CIAs continue to represent a very small proportion (0.4%) of total veterinary antibiotic sales in tonnes.
3. Antibiotic usage
3.1 Antibiotic usage by food-producing animal species
Antibiotic usage refers to the amount of antibiotics prescribed and/or administered per sector. The data have been collected and provided to the VMD by the animal industry on a voluntary basis. Coverage is at least 83% for all sectors shown and calculated to represent the entire population.
Infographic showing the antibiotic use in tonnes in food producing animal species for 2025, in mg/kg in 2025, the change since 2025 in mg/kg and the percentage change since the date of first publication and annual trends since data was first published by each sector.
-
Pigs: 57.3 tonnes which is equivalent to 44.8 mg/kg. This was a 5.3 mg/kg decrease since 2024 and represents an overall decrease of 72% since 2015.
- 2015 - 159.9 mg/kg
- 2016 - 105.8 mg/kg
- 2017 - 78.6 mg/kg
- 2018 - 63.9 mg/kg
- 2019 - 64.2 mg/kg
- 2020 - 61.0 mg/kg
- 2021 - 50.7 mg/kg
- 2020 - 41.5 mg/kg
- 2023 - 49.2 mg/kg
- 2024 - 50.0 mg/kg
- 2025 - 44.8 mg/kg
-
Gamebirds: 11.4 tonnes. This was a 0.3 tonnes increase since 2024 and represents and overall decrease of 43% since 2016.
- 2016 - 20 tonnes
- 2017 - 12.6 tonnes
- 2018 - 9.2 tonnes
- 2019 - 10.0 tonnes
- 2020 - 5.7 tonnes
- 2021 - 8.9 tonnes
- 2020 - 6.7 tonnes
- 2023 - 9.9 tonnes
- 2024 - 11.1 tonnes
- 2025 - 11.4 tonnes
-
Broilers: 8.7 tonnes which is equivalent to 3.8 mg/kg. This was a 0.9 mg/kg decrease since 2024 and represents an overall decrease of 81% since 2015.
- 2014 - 20.3 mg/kg
- 2015 - 11.4 mg/kg
- 2016 - 7.1 mg/kg
- 2017 - 4.1 mg/kg
- 2018 - 5.2 mg/kg
- 2019 - 7.3 mg/kg
- 2020 - 6.8 mg/kg
- 2021 - 5.7 mg/kg
- 2022 - 5.9 mg/kg
- 2023 - 5.6 mg/kg
- 2024 - 4.7 mg/kg
- 2025 - 3.8 mg/kg
-
Salmon: 2.4 tonnes which is equivalent to 12.4 mg/kg. This was a 4.2 mg/kg increase since 2024 and represents an overall decrease of 23% since 2015.
- 2017 - 16.1 mg/kg
- 2018 - 6.7 mg/kg
- 2019 - 13.5 mg/kg
- 2020 - 29.3 mg/kg
- 2021 - 43.1 mg/kg
- 2022 - 18.6 mg/kg
- 2023 - 24.8 mg/kg
- 2024 - 8.1 mg/kg
- 2025 - 12.4 mg/kg
-
Laying Hens: 1.9 tonnes which is equivalent to 0.25% bird days. This was a 0.02% bird day decrease since 2024 and represents an overall decrease of 62% since 2015.
- 2016 - 0.67% bird days
- 2017 - 0.57% bird days
- 2018 - 0.55% bird days
- 2019 - 0.68% bird days
- 2020 - 0.47% bird days
- 2021 - 0.33% bird days
- 2022 - 0.23% bird days
- 2023 - 0.22% bird days
- 2024 - 0.28% bird days
- 2025 - 0.25% bird days
-
Turkeys: 1.6 tones which is equivalent to 18.1 mg/kg. This was a 1.6 mg/kg decrease since 2024 and represents an overall decrease of 83% since 2014.
- 2014 - 108.1 mg/kg
- 2015 - 98.4 mg/kg
- 2016 - 42.6 mg/kg
- 2017 - 22.3 mg/kg
- 2019 - 23 mg/kg
- 2020 - 12.7 mg/kg
- 2021 - 21 mg/kg
- 2022 - 17.4 mg/kg
- 2023 - 16.6 mg/kg
- 2024 - 19.7 mg/kg
- 2025 - 18.1 mg/kg
-
Trout: 0.05 tonnes which is equivalent to 6.9 mg/kg. This was a 1.8 mg/kg decrease since 2024 and represents an overall decrease of 64% since 2014.
- 2017 - 19.2 mg/kg
- 2018 - 13.0 mg/kg
- 2019 - 9.7 mg/kg
- 2020 - 13.9 mg/kg
- 2021 - 9.0 mg/kg
- 2022 - 44.1 mg/kg
- 2023 - 6.9 mg/kg
- 2024 - 5.1 mg/kg
- 2025 - 6.9 mg/kg
-
Ducks: 0.001 tonnes which is equivalent to 0.3 mg/kg. This was a 0.1 mg/kg increase since 2024 and represents an overall decrease of 95% since 2014.
- 2014 - 6.3 mg/kg
- 2015 - 3.4 mg/kg
- 2016 - 1.4 mg/kg
- 2017 - 0.7 mg/kg
- 2019 - 0.7 mg/kg
- 2020 - 1.1 mg/kg
- 2021 - 0.7 mg/kg
- 2022 - 0.1 mg/kg
- 2023 - 0.2 mg/kg
- 2024 - 0.2 mg/kg
- 2025 - 0.3 mg/kg
Infographic showing the use of HP-CIAs in kg, change since 2024 and change since data was first published and annual trends since data was first published by each sector:
-
Trout: 28.7 kg which is equivalent to 4.0 mg/kg. This is a 2.4 mg/kg increase since 2024 and represents an overall decrease of 40% since date of first publication in 2017.
- 2017 - 6.6 mg/kg
- 2018 - 5.8 mg/kg
- 2019 - 2.4 mg/kg
- 2020 - 4.3 mg/kg
- 2021 - 3.2 mg/kg
- 2022 - 2.2 mg/kg
- 2023 - 1.8 mg/kg
- 2024 - 1.5 mg/kg
- 2025 - 4.0 mg/kg
-
Gamebirds: 15 kg. This is a 30.1 kg decrease since 2024 and represents an overall decrease of 77% since date of first publication in 2016.
- 2016 – 64.1 kg
- 2017 – 49.6 kg
- 2018 – 47.0 kg
- 2019 - 57.8 kg
- 2020 – 21.3 kg
- 2021 – 26.5 kg
- 2022 – 23.2 kg
- 2023 – 27.7 kg
- 2024 – 45.1 kg
- 2025 - 15.0 kg
-
Pigs: 8.4 kg which is equivalent to 0.007 mg/kg. This is a 0.002 mg/kg increase since 2024 and represents an overall decrease of 99.9 % since date of first publication in 2015.
- 2015 – 0.56
- 2016 – 0.15
- 2017 - 0.06
- 2018 – 0.04
- 2019 – 0.02
- 2020 – 0.03
- 2021 – 0.02
- 2022 – 0.007
- 2023 - 0.004
- 2024 – 0.005
- 2025 - 0.007
-
Meat poultry: Meat Poultry: 1.7 kg which is equivalent to 0.0007 mg/kg. This is a 0.0001 mg/kg decrease since 2024 and represents an overall decrease of 99.9% since date of first publication in 2014.
- 2014 - 0.51
- 2015 - 0.24
- 2016 - 0.05
- 2017 - 0.01
- 2018 - 0.007
- 2019 - 0.004
- 2020 - 0.003
- 2021 - 0.02
- 2022 - 0.00
- 2023 - 0.002
- 2024 - 0.0009
- 2025- 0.0007
-
Laying hens: 1.3 kg which is equivalent to 0.0003% bird days. This is an decrease of 0.0004% bird days since 2024 and represents an overall decrease of 57% since date of first publication in 2016.
- 2016 - 0.03 %
- 2017 - 0.00 %
- 2018 - 0.00 %
- 2019 - 0.00 %
- 2020 - 0.00 %
- 2021 - 0.00 %
- 2022 - 0.00 %
- 2023 - 0.00 %
- 2024 - 0.0007 %
- 2025 - 0.0003%
4. Antibiotic resistance- harmonised monitoring
4.1 Key resistance outcome indicators: E. coli
The harmonised monitoring outcome indicators combine results from healthy pigs and poultry at slaughter to give an overall picture of antimicrobial resistance (AMR), and are internationally comparable. The percentage of E. coli with full susceptibility has remained at similar levels since the substantial decrease between 2023 and 2024. This is predominantly due to the increased resistance in broilers in 2024 with a slight increase in full susceptibility in pigs in 2025. Multi-drug resistance (MDR) has increased slightly by 2% in 2025, but remains lower than in 2014/2015.
Infographic showing the proportion of E. coli isolates showing full susceptibility to the panel of antibiotics tested and the percentage of multi-drug resistant isolates:
2014/2015 - the percentage of E. coli isolates fully susceptible was 17.2% - the percentage of multi-drug resistant isolates was 57.7%
2015/2016 - the percentage of E. coli isolates fully susceptible was 19.3% - the percentage of multi-drug resistant isolates was 49.2%
2016/2017 - the percentage of E. coli isolates fully susceptible was 22.1% - the percentage of multi-drug resistant isolates was 45.9%
2017/2018 - the percentage of E. coli isolates fully susceptible was 34.0% - the percentage of multi-drug resistant isolates was 35.9%
2018/2019 - the percentage of E. coli isolates fully susceptible was 33.2% - the percentage of multi-drug resistant isolates was 35.7%
2019/2020 - the proportion of E. coli isolates fully susceptible was 37.7% - the percentage of multi-drug resistant isolates was 30.9%
2020/2021 - the percentage of E. coli isolates fully susceptible was 39.3% - the percentage of multi-drug resistant isolates was 30.2%
2021/2022 - the percentage of E. coli isolates fully susceptible was 41.1% - the percentage of multi-drug resistant isolates was 30.3%
2022/2023 - the percentage of E. coli isolates fully susceptible was 43.5% - the percentage of multi-drug resistant isolates was 26.9%
2023/2024 - the percentage of E. coli isolates fully susceptible was 35.1% - the percentage of multi-drug resistant isolates was 26.6%
2024/2025 - the percentage of E. coli isolates fully susceptible was 34.1% - the percentage of multi-drug resistant isolates was 29.0%
5. Resistance in Salmonella in pigs
Resistance in Salmonella in pigs showed the most notable improvement, with full susceptibility increasing to 57% in 2025. MDR continued to decrease and no resistance to HP-CIAs or human- only antibiotics were detected.
Infographic showing the percentage of Salmonella isolated from pigs that are fully susceptible to the panel of antibiotics tested and the percentage of multi-drug resistant isolates:
-2021, the percentage of Salmonella isolates fully susceptible was 39%. The percentage of multi-drug resistant isolates was 50%. - 2023, the percentage of Salmonella isolates fully susceptible was 42%. The percentage of multi-drug resistant isolates was 38%. - 2025, the percentage of Salmonella isolates fully susceptible was 57%. The percentage of multi-drug resistant isolates was 34%.
6. New Surveillance in pigs
E. faecium and C. coli were similar to 2023, with 28% of E. faecium and 1.8% of C. coli being MDR. Vancomycin resistance was detected in E. faecium for the first time.
Infographic showing the percentage of E. faecium and C. coli isolated from pigs that are fully susceptible to the panel of antibiotics tested and the percentage of multi-drug resistant isolates in 2025:
- E. faecium, the percentage fully susceptible isolates was 17.6. The percentage of multi-drug resistant isolates was 28.4%.
- C. coli, the percentage fully susceptible isolates was 20. The percentage of multi-drug resistant isolates was 1.8%.
7. Using selective media to detect E. coli
We also perform a more sensitive type of testing using selective media which inhibits the growth of susceptible bacteria but allows bacteria with specific resistances to multiply, making them easier to detect. This tells us the percentage of individual sample containing resistance to the HP-CIAs, even when present in very low numbers. Carriage of ESBL-/AmpC-producing E. coli increased 23% in pigs in 2023 to 32% in 2025. More than a third of these isolates were resistant to both third- and fourth- generation cephalosporins and fluoroquinolone antibiotics.
Infographic showing carriage of ESBL- and/or AmpC- producing E. coli pigs which are resistant to third and fourth generation cephalosporins and penicillins:
- 2015 - 27.5%
- 2017 - 21.6%
- 2019 - 18.8%
- 2021 - 30.1%
- 2023 - 22.6%
- 2025 - 31.5%
Infographic showing carriage of carbapenamase producing E. coli and colistin resistant E. coli in 2025:
- Carriage of carbapenamase producing E. coli was 0.3%, carriage of colistin resistant E. coli was 0.8%.
8. Antibiotic resistance- clinical surveillance
Clinical surveillance is a programme of passive surveillance that evaluates AMR in bacteria isolated from diagnostic samples, including those with zoonotic potential. As this kind of scanning surveillance is subject to biases and differences in the number of samples, the results are not representative of the UK’s wider animal populations.
8.1 Overview of sampling
7,866 isolates were tested for AMR in England and Wales in 2025. Of these, 4,929 were Salmonella and 1,837 were Escherichia coli. Major sources of isolates included: poultry (26%), cattle (16%), pigs (15%), dogs (10%), sheep (8.9%) and feed (15%).
8.2 Percentage of E. coli in livestock with limited treatment options
In 2025, 18% of all livestock E. coli isolates had limited treatment options (resistance to four or more antibiotics). This is a 68% reduction compared with 2014.
Higher resistance was observed in E. coli isolates from young animals than from adults. For lambs and calves, neonatal animals have the highest percentage of isolates with limited treatment options, whilst post-weaning pigs have higher resistance than neonates.
The percentage of E. coli with limited treatment options has declined substantially in young pigs, cattle and sheep since 2014.
Infographic showing percentage of all E. coli isolates from livestock tested between 2014 and 2025 which had limited treatment options, meaning they were resistant to four or more individual antimicrobials:
- 2014 - 56.8%
- 2015 - 57.8%
- 2016 - 49.8%
- 2017 - 39.5%
- 2018 - 34.5%
- 2019 - 31.2%
- 2020 - 27.9%
- 2021 - 29.7%
- 2022 - 24.3%
- 2023 - 18.2%
- 2024 - 19.1%
- 2025 - 18.1%
Infographic showing percentage of E. coli isolates from cattle by age group (neo-natal, pre-weaning, and adult) tested between 2014 and 2025 which had limited treatment options:
- Neonatal cattle:
- 2014 - 75%
- 2015 - 77%
- 2016 - 72%
- 2017 - 66.8%
- 2018 - 61.9%
- 2019 - 62.3%
- 2020 - 68.4%
- 2021 - 52.1%
- 2022 - 57%
- 2023 - 37.3%
- 2024 - 37.3%
- 2025 - 40.5%
- Pre- weaning cattle:
- 2014 - 64%
- 2015 - 64%
- 2016 - 63%
- 2017 - 62.5%
- 2018 - 47.7%
- 2019 - 55.9%
- 2020 - 45.3%
- 2021 - 45.2%
- 2022 - 44%
- 2023 - 27.2%
- 2024 - 33.6%
-
2025 - 33.8%
- Adult cattle:
- 2016 - 24%
- 2017 - 9.2%
- 2018 - 13.2%
- 2019 - 9.1%
- 2020 - 12.5%
- 2021 - 8.6%
- 2022 - 13.8%
- 2023 - 1.7%
- 2024 - 6.7%
- 2025 - 9.0%
Infographic showing percentage of all E. coli isolates from sheep by age group (neonatal, pre-weaning, and adult) tested between 2014 and 2025 which had limited treatment options:
- Neo-natal sheep:
- 2014 - 46%
- 2015 - 54%
- 2016 - 52%
- 2017 - 41.3%
- 2018 - 43.5%
- 2019 - 32.1%
- 2020 - 37.3%
- 2021 - 37.5%
- 2022 - 18.6%
- 2023 - 9.6 %
- 2024 - 23.5%
- 2025 - 14.3%
- Pre-weaning sheep
- 2016 - 23%
- 2018 - 25%
- 2019 - 13.8%
- 2020 - 6.7%
- 2021 - 3.3%
- 2022 - 6.5%
- 2023 - 13.3%
- 2024 - 9.6%
- 2025 - 4.5%
- Adult sheep
- 2016 - 7%
- 2017 - 8.3%
- 2018 - 7.7%
- 2019 - 12.9%
- 2020 - 3.6%
- 2021 - 3.8%
- 2022 - 2.3%
- 2023 - 0%
- 2024 - 5.8%
- 2025 -3.1%
8.3 Resistance in Salmonella
Certain Salmonella serovars are regulated, due to public health concerns, and there are differences in resistance profiles between serovars as well as animal species. Monophasic S. Typhimurium isolates from pigs and feed, including raw pet food, had significantly higher levels of limited treatment options compared to all other sources.
Infographic showing percentage and number of Salmonella isolates resistant to 4 or more antimicrobials in different Salmonella serovars across different animal species:
S. Typhimurium:
- Pigs- 147 isolates, 94.6% resistant to 4 or more antimicrobials
- Chickens-7 isolates, 0% resistant to 4 or more antimicrobials
- Cattle- 61 isolates, 1.6% resistant to 4 or more antimicrobials
- Sheep- 7 isolates, 0% resistant to 4 or more antimicrobials
- Dogs- 64 isolates, 14.1 resistant to 4 or more antimicrobials
- Horses- 47 isolates, 6.4% resistant to 4 or more antimicrobials
- Feed- 72 isolates, 11.1% resistant to 4 or more antimicrobials
Monophasic S. Typhimurium:
- Pigs - 80 isolates, 92.5% resistant to 4 or more antimicrobials
- Chickens -2 isolates, 50% resistant to 4 or more antimicrobials
- Cattle - 3 isolates, 66.7% resistant to 4 or more antimicrobials
- Sheep - No isolates
- Dogs - 33 isolates, 60.6% resistant to 4 or more antimicrobials
- Horses - 3 isolates, 100% resistant to 4 or more antimicrobials
- Feed - 27 isolates, 88.9% resistant to 4 or more antimicrobials
S. Enteritidis
- Pigs - No isolates
- Chickens- 39 isolates, 87.2% resistant to 4 or more antimicrobials
- Cattle - 1 isolate, 0% resistant to 4 or more antimicrobials
- Sheep - No isolates,
- Dogs - 16 isolates, 0% resistant to 4 or more antimicrobials
- Horses - 13 isolates, 0% resistant to 4 or more antimicrobials
- Feed - 13 isolates, 0% resistant to 4 or more antimicrobials
8.4 Private Laboratories Initiative (PLI)
The PLI was established to help improve the sharing of AMR data held by private veterinary laboratories with government. This year, for the first time, the VARSS report includes verified data from cats and dogs provided by the University of Liverpool. Testing in dogs and cats covered four bacteria: E. coli, K. pneumoniae, S. aureus and S. pseudintermedius
9. Background
9.1 How are sales data collected
In the UK, from 2005 it has been a statutory requirement for pharmaceutical companies to report to the VMD the quantity of antibiotics sold for use in animals. This data does not take into account special imports of veterinary antibiotics not authorised for sale in the UK but authorised elsewhere, and some medicines may not be used in the same year (or at all if the product goes out of date before being used). However, they serve as the best currently available approximation of the quantity of antibiotics administered to animals within the UK.
9.2 How are usage data collected
Antibiotic usage data, i.e. the amount of antibiotics purchased, prescribed and/or administered, has the potential to provide much more precise estimates of use as it allows antibiotic use to be split by species/sector and also include antibiotics imported under the special import scheme.
Antibiotic usage data collection systems have been put in place by the British Poultry Council (meat poultry), the British Egg Industry Council (laying hens),the Game Farmers Association and British Veterinary Poultry Association (gamebirds), the electronic Medicines Book (pigs), the British Trout Association (trout), Salmon Scotland (Salmon) and Medicine Hub (ruminants). This data has been voluntarily provided by producers (pigs, poultry and laying hens), feed companies (gamebirds) and veterinary practices (gamebirds and fish).
9.3 What are Critically Important Antibiotics (CIAs)
HP-CIA refers antibiotics that are vitally important to human medicine and where there is the highest risk of transmission from non-human sources. These are defined by the World Health Organisation (WHO) List of Medically Important Antimicrobials, and include third- and fourth- generation cephalosporins, polymyxins (e.g. colistin) and quinolones/fluoroquinolones This also aligns with “Category B” in the European Antimicrobial Expert Group report categorisation (AMEG).
9.4 How is antibiotic resistance interpreted
Antibiotic resistance in bacteria isolated from animals is monitored through two distinct surveillance programmes: harmonised monitoring and clinical surveillance. The harmonised monitoring scheme is a UK-wide programme in which we test bacteria from the gut of healthy pigs and poultry at slaughter, and the National Control Programme for Salmonella, giving us a representative picture of resistance in key livestock species entering the food chain. Clinical surveillance involves the testing of bacteria that have been isolated from clinical samples submitted by farmers and private veterinarians to government laboratories in England and Wales.
Susceptibility testing for harmonised monitoring is performed using broth microdilution to determine minimum inhibitory concentrations (MICs). Resistance is assessed using EUCAST (European Committee on Antimicrobial Susceptibility Testing) epidemiological cut-off values (ECOFFs) where possible. Where no EUCAST values were available, European Food Safety Authority (EFSA) recommended cut-off values were used. Where neither defined values are available, tentative EUCAST ECOFF values were applied. Results interpreted using ECOFFs are reported in full in Supplementary Material 5.
In the 2025 clinical surveillance programme, the majority of the results presented were assessed by disc diffusion techniques, and interpreted using BSAC (British Society for Antimicrobial Chemotherapy) human clinical breakpoints (CBPs) where available. Broth microdilution testing was introduced in UK-VARSS 2020 and continues to be developed and applied to an increasing number of organisms over the last four years. MIC results have been interpreted using veterinary clinical breakpoints from Clinical and Laboratory Standards Institute (CLSI) in the first instance, or Comité de l’Antibiogramme de la Société Française de Microbiologie (CA-SFM) when these are not available; if veterinary clinical breakpoints were not available, human clinical breakpoints were used. Full details of the methods used are available in Supplementary Material 6.